Table 3.

Antimicrobial Susceptibility Patterns of Bacterial Isolates Among Women Attending at Gondar Town Health Facilities, Northwest Ethiopia, February 1 to May 31, 2019

Antibiotics	Isolated Bacteria (n=59)
	E. fecalis (n=19)		S. aureus (n=13)		CONS (n=8)		E. coli (n=12)		K. pneumoniae (n=4)		K. ozanae (n=3)
	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)
Amox/clav (30 µg)	N/D	N/D	N/D	N/D	N/D	N/D	3(25)	9(75)	1(25)	3(75)	0(0)	3(100)
Ampicillin (25 µg)	N/D	N/D	N/D	N/D	N/D	N/D	0(0)	12(100)	N/D	N/D	N/D	N/D
Cefoxitin (30 µg)	N/D	N/D	13(100)	0(0)	8(100)	0(0)	N/D	N/D	N/D	N/D	N/D	N/D
Ceftriaxone (30 µg)	N/D	N/D	N/D	N/D	N/D	N/D	12(100)	0(0)	3(75)	1(25)	1(33.3)	2(66.7)
Chloramphenicol(30µg)	10(52.63)	9(47.37)	5(38.5)	8(61.5)	6(75)	2(25)	10(83.3)	2(16.7)	2(50)	2(50)	3(100)	0(0)
Ciprofloxacin (5 µg)	N/D	N/D	13(100)	0(0)	8(100)	0(0)	12(100)	0(0)	4(100)	0(0)	3(100)	0(0)
Clindamycin (2 µg)	N/D	N/D	13(100)	0(0)	8(100)	0(0)	N/D	N/D	N/D	N/D	N/D	N/D
Doxycycline (30 µg)	8(42.11)	11(57.89)	N/D	N/D	N/D	N/D	N/D	N/D	N/D	N/D	N/D	N/D
Erythromycin (15 µg)	16(84.2)	3(15.8)	12(92.3)	1(7.7)	6(75)	2(25)	N/D	N/D	N/D	N/D	N/D	N/D
Gentamicin (10 µg)	N/D	N/D	13(100)	0(0)	8(100)	0(0)	12(100)	0(0)	4(100)	0(0)	3(100)	0(0)
Meropenem(10 µg)	N/D	N/D	N/D	N/D	N/D	N/D	12(100)	0(0)	4(100)	0(0)	3(100)	0(0)
Penicillin (10 µg)	9(47.37)	10(52.63)	0(0)	13(100)	0(0)	8(100)	N/D	N/D	N/D	N/D	N/D	N/D
Tetracycline (30 µg)	N/D	N/D	0(0)	13(100)	4(50)	4(50)	0(0)	12(100)	1(25)	3(75)	1(33.3)	2(66.7)
TMP/SMX(1.25/23.75 µg)	N/D	N/D	6(46.15)	7(53.85)	5(62.5)	3(37.5)	4(33.3)	8(66.7)	1(25)	3(75)	1(33.3)	2(66.7)
Vancomycin (30 µg).	19(100)	0(0)	N/D	N/D	N/D	N/D	N/D	N/D	N/D	N/D	N/D	N/D

Abbreviation: N/D, not done.